Attached files
| file | filename |
|---|---|
| EX-32.2 - EX-32.2 - MyoKardia, Inc. | myok-ex322_9.htm |
| EX-32.1 - EX-32.1 - MyoKardia, Inc. | myok-ex321_7.htm |
| EX-31.2 - EX-31.2 - MyoKardia, Inc. | myok-ex312_6.htm |
| EX-31.1 - EX-31.1 - MyoKardia, Inc. | myok-ex311_8.htm |
| EX-10.18 - EX-10.18 - MyoKardia, Inc. | myok-ex1018_29.htm |
| EX-10.17 - EX-10.17 - MyoKardia, Inc. | myok-ex1017_30.htm |
| EX-10.16 - EX-10.16 - MyoKardia, Inc. | myok-ex1016_31.htm |
| 10-K - 10-K - MyoKardia, Inc. | myok-10k_20171231.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Forms S‑3 (Nos. 333-219220 and 333-215443) and Forms S-8 (Nos. 333-222866, 333-215822 and 333-207674) of MyoKardia, Inc. of our report dated March 8, 2018 relating to the financial statements, which appears in this Form 10‑K.
/s/ PricewaterhouseCoopers LLP
San Jose, California
March 8, 2018